MY150861A - Neutron activated 153sm labelled microspheres - Google Patents
Neutron activated 153sm labelled microspheresInfo
- Publication number
- MY150861A MY150861A MYPI2012700480A MY150861A MY 150861 A MY150861 A MY 150861A MY PI2012700480 A MYPI2012700480 A MY PI2012700480A MY 150861 A MY150861 A MY 150861A
- Authority
- MY
- Malaysia
- Prior art keywords
- microspheres
- labelled
- neutron activated
- labelled microspheres
- neutron
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G4/00—Radioactive sources
- G21G4/04—Radioactive sources other than neutron sources
- G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
- G21G4/08—Radioactive sources other than neutron sources characterised by constructional features specially adapted for medical application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
- A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
- A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
- A61K51/1251—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles micro- or nanospheres, micro- or nanobeads, micro- or nanocapsules
-
- G—PHYSICS
- G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
- G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
- G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
- G21G1/04—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
- G21G1/06—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Nanotechnology (AREA)
- Medicinal Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a method of preparation of 153Sm labelled microspheres, comprising the steps of incorporating a 152Sm compound into insoluble ion-exchange resin or glass beads and subsequently performing neutron activation of the incorporated samarium microspheres. It further includes radioactive microspheres containing 153SmCl3 or a hydrate thereof and the clinical use of such radiolabelled microspheres.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2012700480 MY150861A (en) | 2012-07-18 | 2012-07-18 | Neutron activated 153sm labelled microspheres |
PCT/MY2013/000147 WO2014030993A1 (en) | 2012-07-18 | 2013-08-16 | Neutron activated 153sm labelled microspheres |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI2012700480 MY150861A (en) | 2012-07-18 | 2012-07-18 | Neutron activated 153sm labelled microspheres |
Publications (1)
Publication Number | Publication Date |
---|---|
MY150861A true MY150861A (en) | 2014-03-06 |
Family
ID=49162192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2012700480 MY150861A (en) | 2012-07-18 | 2012-07-18 | Neutron activated 153sm labelled microspheres |
Country Status (2)
Country | Link |
---|---|
MY (1) | MY150861A (en) |
WO (1) | WO2014030993A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2859971C (en) * | 2011-12-21 | 2020-08-04 | Isotherapeutics Group, Llc | Radioactive compositions and methods for their therapeutic use |
EP3645058A4 (en) * | 2017-06-28 | 2021-05-12 | The Regents of The University of California | Composite embolization beads |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342283A (en) * | 1990-08-13 | 1994-08-30 | Good Roger R | Endocurietherapy |
WO1994026755A1 (en) * | 1993-05-06 | 1994-11-24 | The Dow Chemical Company | Bicyclopolyazamacrocyclophosphonic acid complexes, a process for their preparation, and their conjugates, for use as radiopharmaceuticals |
KR20100135312A (en) * | 2008-04-24 | 2010-12-24 | 디 오스트레일리언 내셔널 유니버시티 | Methods for radiolabelling synthetic polymers |
-
2012
- 2012-07-18 MY MYPI2012700480 patent/MY150861A/en unknown
-
2013
- 2013-08-16 WO PCT/MY2013/000147 patent/WO2014030993A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014030993A1 (en) | 2014-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2499645A4 (en) | Techniques for on-demand production of medical isotopes such as mo-99/tc-99m and radioactive iodine isotopes including i-131 | |
EP2846695A4 (en) | Nuclear medicine tomography systems, detectors and methods | |
HK1210287A1 (en) | Systems, methods and articles for enhancing wellness associated with habitable environments | |
EP2669289A4 (en) | Phosphorus substituted group-containing quinoline-like compound, its preparation process, medical composition containing the compound and application | |
BR112014028588A2 (en) | methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding the same and an orthogone pylrs synthase. | |
GB201219670D0 (en) | Debugging multithreaded code | |
EP2840497A4 (en) | Method, system and an executable piece of code for the virtualisation of a hardware resource associated with a computer system | |
WO2015036867A3 (en) | Method and system for instruction scheduling | |
SG11201502157VA (en) | Method for producing cyanogen halide, cyanateester compound and method for producing the same,and resin composition | |
BR112015008723A2 (en) | apparatus for releasing chemical agent into a wellbore, method for providing a chemical agent and method | |
MX351508B (en) | Protective patient footwear design and manufacturing system and methods. | |
GB201013767D0 (en) | Identification of ligands and their use | |
TWI562022B (en) | Optical mouse with cursor rotating ability, the motion detector and method thereof | |
EP2967465A4 (en) | System for the detection of gamma radiation from a radioactive analyte | |
WO2012138379A3 (en) | Multifunctional chelator-free radioactive nanoparticles for imaging and therapy | |
WO2015153772A3 (en) | Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography | |
PT2535358T (en) | Radioactive metal-labeled anti-cadherin antibody | |
IL278795A (en) | Microspheres containing radioactive isotopes and other markers, and associated methods | |
MX2015005313A (en) | Elution of biomolecules from multi-modal resins using mes and mops as mobile phase modifiers. | |
EP3336851A4 (en) | Nuclear reactor system for extinguishing radioactivity | |
EP2840496A4 (en) | Method, system and an executable piece of code for controlling the use of hardware resources of a computer system | |
HK1210856A1 (en) | Methods, system and associated computer executable code for facilitating credit transactions | |
MX336369B (en) | Use of ellagic acid as an anti-dandruff agent. | |
MY150861A (en) | Neutron activated 153sm labelled microspheres | |
EP3005374A4 (en) | Loss-of-coolant accident reactor cooling system |